NPI: 1083648810 · SAN FRANCISCO, CA 94110 · Case Manager/Care Coordinator · NPI assigned 07/10/2006
Authorized official ARNOLD, TIMOTHY controls 20+ related entities in our dataset. Read more
| Authorized Official | ARNOLD, TIMOTHY (DEPUTY DIRECTOR, PFS) |
| NPI Enumeration Date | 07/10/2006 |
Other providers sharing the same authorized official: ARNOLD, TIMOTHY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 647,428 | $2.66M |
| 2019 | 471,333 | $1.90M |
| 2020 | 239,019 | $1.05M |
| 2021 | 249,394 | $2.47M |
| 2022 | 264,015 | $6.28M |
| 2023 | 266,582 | $17.05M |
| 2024 | 251,270 | $25.00M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T2033 | Residential care, not otherwise specified (nos), waiver; per diem | 14,584 | 964 | $10.07M |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 12,172 | 3,713 | $6.16M |
| 0760 | 87,873 | 77,697 | $3.90M | |
| G9012 | Other specified case management service not elsewhere classified | 7,765 | 2,624 | $3.71M |
| H0014 | Alcohol and/or drug services; ambulatory detoxification | 3,570 | 1,874 | $3.27M |
| H0043 | Supported housing, per diem | 2,620 | 2,549 | $2.70M |
| J9271 | Injection, pembrolizumab, 1 mg | 163 | 69 | $1.18M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 68,217 | 61,698 | $1.12M |
| 0450 | Emergency room services | 13,841 | 12,569 | $889K |
| 87536 | 11,890 | 11,664 | $865K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 456 | 402 | $772K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 155,448 | 143,769 | $595K |
| 90750 | 1,326 | 1,326 | $576K | |
| 90677 | 2,223 | 2,220 | $563K | |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 116 | 64 | $550K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 85,353 | 79,720 | $535K |
| Z7502 | 13,488 | 13,364 | $512K | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 118,578 | 52,400 | $477K |
| 80053 | Comprehensive metabolic panel | 55,207 | 53,070 | $447K |
| 83036 | Hemoglobin; glycosylated (A1C) | 53,794 | 53,515 | $414K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 25,825 | 25,387 | $412K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 15,891 | 14,144 | $408K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 114 | 82 | $406K |
| 90651 | 3,524 | 3,514 | $393K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 62,074 | 58,748 | $368K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24,687 | 23,352 | $363K |
| 80061 | Lipid panel | 35,312 | 35,161 | $362K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 5,708 | 5,550 | $333K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 70,650 | 68,207 | $331K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12,253 | 11,164 | $324K |
| 0002A | 11,929 | 11,928 | $307K | |
| 0001A | 12,577 | 12,576 | $300K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6,522 | 6,435 | $269K |
| 0270 | 8,829 | 3,980 | $250K | |
| 90739 | 696 | 693 | $238K | |
| 84443 | Thyroid stimulating hormone (TSH) | 21,501 | 21,206 | $224K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6,584 | 4,916 | $204K |
| 86780 | 13,132 | 12,764 | $202K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 185 | 183 | $200K |
| 90715 | 6,930 | 6,875 | $190K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,514 | 2,657 | $186K |
| 82803 | 12,501 | 11,418 | $185K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9,387 | 8,548 | $184K |
| 90832 | Psychotherapy, 30 minutes with patient | 2,827 | 2,033 | $178K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,442 | 3,398 | $171K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,369 | 1,976 | $166K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,811 | 2,809 | $163K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,704 | 3,511 | $159K |
| 0004A | 6,052 | 6,050 | $153K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 65 | 65 | $152K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 10,858 | 10,815 | $146K |
| Z7610 | 23,264 | 4,242 | $144K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,238 | 1,795 | $132K |
| 86803 | 12,715 | 12,678 | $130K | |
| 90791 | Psychiatric diagnostic evaluation | 575 | 544 | $130K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 715 | 615 | $128K |
| 92250 | 7,732 | 7,031 | $128K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 3,434 | 3,130 | $126K |
| 82105 | 3,420 | 3,383 | $126K | |
| 88142 | 9,116 | 9,096 | $121K | |
| J3490 | Unclassified drugs | 13,424 | 9,148 | $120K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 220,488 | 166,256 | $113K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,794 | 3,793 | $113K |
| 67028 | Intravitreal injection of a pharmacologic agent | 902 | 829 | $107K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,291 | 2,856 | $101K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2,368 | 2,167 | $100K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,558 | 1,490 | $99K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 31,959 | 31,559 | $99K |
| 0361 | 661 | 454 | $95K | |
| 71046 | Radiologic examination, chest; 2 views | 11,023 | 10,658 | $95K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 5,845 | 5,679 | $93K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2,602 | 2,409 | $92K |
| 99199 | Unlisted special service, procedure or report | 3,785 | 3,447 | $91K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,143 | 2,096 | $91K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,557 | 4,316 | $88K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,635 | 2,399 | $88K |
| 80076 | 21,665 | 20,694 | $86K | |
| 85027 | 24,625 | 24,105 | $83K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 3,931 | 3,913 | $82K |
| 74183 | 437 | 435 | $81K | |
| 99188 | 3,163 | 3,146 | $79K | |
| 99201 | 1,381 | 924 | $75K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 158 | 158 | $75K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1,497 | 1,278 | $71K |
| 92134 | 7,777 | 7,404 | $70K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,905 | 1,890 | $67K |
| 82728 | 6,785 | 6,716 | $66K | |
| 86361 | 4,598 | 4,569 | $65K | |
| Z9725 | 1,504 | 1,335 | $65K | |
| 90686 | 14,231 | 14,204 | $63K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5,690 | 5,613 | $63K |
| 0710 | 1,816 | 1,643 | $62K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,324 | 2,275 | $61K |
| 90619 | 890 | 886 | $60K | |
| 59840 | 1,218 | 1,113 | $59K | |
| 0360 | 495 | 251 | $59K | |
| 83605 | 6,719 | 6,394 | $58K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,132 | 1,902 | $58K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14,480 | 13,759 | $58K |
| 87340 | 9,299 | 9,212 | $57K | |
| 0510 | 6,632 | 5,771 | $57K | |
| 90716 | 2,266 | 2,256 | $57K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 13,106 | 12,573 | $56K |
| J1380 | Injection, estradiol valerate, up to 10 mg | 1,278 | 612 | $55K |
| 59025 | Fetal non-stress test | 3,900 | 2,812 | $55K |
| 0124A | 2,158 | 2,158 | $55K | |
| 0064A | 2,180 | 2,180 | $54K | |
| 90707 | 2,134 | 2,127 | $53K | |
| 87517 | 3,328 | 3,294 | $52K | |
| 88304 | 1,964 | 1,853 | $52K | |
| 0761 | 759 | 649 | $52K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,125 | 757 | $52K |
| 86706 | 8,230 | 8,202 | $51K | |
| 59425 | 586 | 373 | $49K | |
| 71045 | Radiologic examination, chest; single view | 8,970 | 8,697 | $49K |
| 87088 | 12,997 | 12,466 | $49K | |
| 0516 | 4,097 | 3,822 | $47K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,143 | 2,033 | $47K |
| 97039 | 12,213 | 6,812 | $47K | |
| Z7500 | 1,712 | 1,325 | $46K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,944 | 1,268 | $45K |
| 90834 | Psychotherapy, 45 minutes with patient | 919 | 684 | $45K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 505 | 500 | $44K |
| 92523 | 864 | 661 | $44K | |
| 81025 | 16,110 | 15,418 | $43K | |
| 82274 | 5,945 | 5,931 | $43K | |
| 82043 | 11,509 | 11,427 | $42K | |
| 86141 | 7,026 | 6,873 | $41K | |
| 90656 | 2,098 | 2,097 | $40K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 970 | 719 | $40K |
| 86704 | 4,868 | 4,847 | $40K | |
| 82570 | 13,276 | 13,085 | $40K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3,097 | 2,944 | $39K |
| 76801 | 395 | 374 | $39K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 1,013 | 744 | $39K |
| 87522 | Neg quan hep c or qual rna | 2,876 | 2,831 | $39K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5,685 | 3,862 | $37K |
| 0071A | 1,401 | 1,400 | $36K | |
| 0072A | 1,373 | 1,373 | $36K | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 543 | 257 | $35K |
| 73630 | 3,408 | 3,228 | $35K | |
| 83690 | 9,995 | 9,416 | $35K | |
| 92133 | 2,936 | 2,385 | $34K | |
| 97139 | 1,162 | 716 | $34K | |
| 83970 | 2,135 | 2,090 | $33K | |
| 90633 | 3,906 | 3,887 | $33K | |
| 88112 | 995 | 975 | $33K | |
| 11721 | 1,873 | 1,535 | $32K | |
| 84466 | 4,631 | 4,572 | $32K | |
| 86360 | 1,577 | 1,570 | $31K | |
| 90670 | 4,736 | 4,716 | $31K | |
| 76813 | 585 | 543 | $31K | |
| 86708 | 5,125 | 5,110 | $31K | |
| 84439 | 5,900 | 5,758 | $31K | |
| 84484 | 5,933 | 5,392 | $30K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,983 | 1,949 | $30K |
| 99152 | 2,761 | 2,716 | $30K | |
| 84153 | 2,560 | 2,529 | $30K | |
| J2400 | Injection, chloroprocaine hydrochloride, per 30 ml | 1,374 | 1,054 | $29K |
| 96523 | 1,930 | 1,340 | $28K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,176 | 1,873 | $28K |
| 0012A | 1,118 | 1,118 | $28K | |
| 59841 | 566 | 551 | $28K | |
| 82948 | 15,323 | 13,100 | $27K | |
| 70486 | 623 | 615 | $27K | |
| 0011A | 1,340 | 1,340 | $27K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,325 | 968 | $27K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,711 | 1,155 | $27K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 511 | 507 | $26K |
| 86592 | 17,750 | 17,472 | $26K | |
| 81001 | 15,652 | 14,928 | $26K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 197 | 194 | $26K |
| 99215 | Prolong outpt/office vis | 3,781 | 3,626 | $26K |
| 86762 | 2,237 | 2,224 | $26K | |
| 73130 | 2,237 | 2,099 | $25K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 226 | 226 | $24K |
| 90680 | 3,170 | 3,149 | $24K | |
| 72141 | 374 | 371 | $24K | |
| 81002 | 14,491 | 13,525 | $24K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1,319 | 1,310 | $23K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 510 | 509 | $23K |
| 72100 | 1,901 | 1,870 | $23K | |
| 85610 | 13,364 | 12,411 | $23K | |
| 86787 | 2,130 | 2,115 | $23K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 7,294 | 6,910 | $22K |
| 80074 | 227 | 227 | $22K | |
| 83880 | 2,954 | 2,750 | $22K | |
| 85730 | 7,351 | 7,098 | $21K | |
| 90647 | 3,390 | 3,367 | $21K | |
| 97750 | 3,675 | 3,392 | $20K | |
| 73030 | 2,133 | 2,069 | $20K | |
| 92002 | 886 | 882 | $20K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 8,589 | 6,596 | $20K |
| 88141 | 1,894 | 1,893 | $19K | |
| 83735 | 7,931 | 6,690 | $19K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 277 | 259 | $19K |
| 73110 | 1,719 | 1,555 | $18K | |
| 84403 | 1,448 | 1,414 | $18K | |
| 59430 | 1,416 | 1,300 | $18K | |
| 80069 | 3,787 | 3,553 | $18K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,694 | 1,267 | $18K |
| 0134A | 716 | 716 | $18K | |
| 83655 | 4,875 | 4,854 | $18K | |
| 83540 | 5,431 | 5,360 | $18K | |
| 0031A | 664 | 664 | $17K | |
| 99070 | 726 | 417 | $17K | |
| 90837 | Psychotherapy, 53 minutes with patient | 364 | 315 | $17K |
| 87081 | 3,874 | 3,832 | $17K | |
| 90723 | 3,171 | 3,145 | $17K | |
| 97597 | 380 | 306 | $17K | |
| 83020 | 1,198 | 1,171 | $16K | |
| 0003A | 622 | 622 | $16K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 267 | 259 | $16K |
| 86901 | 6,422 | 6,040 | $16K | |
| 87529 | 160 | 158 | $16K | |
| 59426 | 9,998 | 6,645 | $16K | |
| 86850 | 3,728 | 3,510 | $15K | |
| 20610 | 574 | 551 | $15K | |
| 87077 | 2,704 | 2,621 | $15K | |
| 70355 | 2,005 | 1,950 | $15K | |
| 76830 | Ultrasound, transvaginal | 1,125 | 1,090 | $15K |
| 82607 | 3,362 | 3,353 | $15K | |
| 97802 | 3,488 | 2,995 | $15K | |
| 71250 | 804 | 785 | $15K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,131 | 1,100 | $15K |
| 93976 | 416 | 413 | $14K | |
| 86900 | 6,485 | 6,102 | $14K | |
| 87430 | 2,337 | 2,321 | $13K | |
| 29581 | 2,378 | 761 | $13K | |
| 90700 | 1,461 | 1,452 | $13K | |
| 99401 | 4,184 | 3,351 | $13K | |
| 97165 | 141 | 115 | $12K | |
| 90697 | 498 | 495 | $12K | |
| 90746 | 976 | 973 | $12K | |
| 92015 | Determination of refractive state | 2,418 | 2,411 | $12K |
| 82248 | 4,045 | 3,952 | $12K | |
| 87210 | 3,471 | 3,398 | $12K | |
| 70498 | 168 | 166 | $11K | |
| 90710 | 1,263 | 1,260 | $11K | |
| 73610 | 1,578 | 1,502 | $11K | |
| 73562 | 1,121 | 1,111 | $11K | |
| 96900 | 566 | 111 | $11K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,688 | 1,670 | $11K |
| 84460 | 4,644 | 4,345 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,802 | 2,682 | $10K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3,655 | 3,622 | $10K |
| 73564 | 1,245 | 1,218 | $10K | |
| 92558 | 1,390 | 1,150 | $9K | |
| 96415 | 2,048 | 1,562 | $9K | |
| 90696 | 1,191 | 1,188 | $9K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 263 | 263 | $9K |
| 90713 | 327 | 291 | $9K | |
| 92083 | 1,009 | 867 | $9K | |
| 85018 | 4,599 | 4,289 | $8K | |
| 84132 | 7,251 | 6,608 | $8K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,013 | 2,751 | $8K |
| A4268 | Contraceptive supply, condom, female, each | 755 | 748 | $8K |
| 82947 | 3,929 | 3,815 | $8K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 834 | 819 | $8K |
| 84295 | 6,488 | 6,071 | $8K | |
| 85014 | 7,807 | 7,388 | $8K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 2,337 | 1,342 | $8K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 23 | 13 | $8K |
| 85652 | 5,901 | 5,779 | $8K | |
| 87186 | 2,274 | 2,210 | $8K | |
| 52000 | 80 | 80 | $8K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 18,119 | 14,739 | $8K |
| 84450 | 3,259 | 2,962 | $8K | |
| 93971 | 514 | 500 | $7K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,301 | 1,440 | $7K |
| 73080 | 818 | 789 | $7K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,507 | 1,450 | $7K |
| 90714 | 255 | 255 | $7K | |
| 82610 | 261 | 259 | $7K | |
| 76998 | 52 | 52 | $7K | |
| 86580 | 2,034 | 1,937 | $7K | |
| 83516 | 1,170 | 1,151 | $7K | |
| 90732 | 510 | 500 | $6K | |
| P9057 | Red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated, each unit | 56 | 26 | $6K |
| 86160 | 776 | 679 | $6K | |
| 86593 | 2,146 | 2,051 | $6K | |
| 82950 | 1,531 | 1,525 | $6K | |
| 77066 | Tomosynthesis, mammo | 447 | 447 | $6K |
| 84702 | 2,013 | 1,781 | $6K | |
| 88342 | 558 | 525 | $6K | |
| 86038 | 1,340 | 1,333 | $6K | |
| 76770 | 669 | 662 | $6K | |
| 88312 | 1,033 | 695 | $6K | |
| 76642 | 885 | 874 | $6K | |
| H1011 | Family assessment by licensed behavioral health professional for state defined purposes | 66 | 66 | $6K |
| 73502 | 836 | 823 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,158 | 3,821 | $5K |
| 99241 | 814 | 785 | $5K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 509 | 505 | $5K |
| 36415 | Collection of venous blood by venipuncture | 12,799 | 11,062 | $5K |
| 73120 | 948 | 931 | $5K | |
| 84481 | 1,314 | 1,285 | $5K | |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 175 | 148 | $5K |
| 84100 | 3,646 | 3,383 | $5K | |
| 86682 | 259 | 255 | $5K | |
| 86765 | 581 | 573 | $5K | |
| 36000 | 3,465 | 2,454 | $5K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 223 | 220 | $5K |
| 73100 | 632 | 618 | $5K | |
| 73560 | 1,145 | 1,116 | $5K | |
| 93247 | 24 | 23 | $5K | |
| 87631 | 424 | 422 | $5K | |
| 81003 | 4,116 | 4,002 | $5K | |
| 86480 | 809 | 804 | $4K | |
| 87070 | 1,353 | 1,309 | $4K | |
| 70496 | 108 | 106 | $4K | |
| J2704 | Injection, propofol, 10 mg | 1,216 | 568 | $4K |
| 82565 | 4,945 | 4,396 | $4K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,423 | 1,257 | $4K |
| 84156 | 2,306 | 2,222 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,111 | 1,746 | $4K |
| 72052 | 112 | 112 | $4K | |
| Z1034 | 57 | 55 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 472 | 438 | $4K |
| 96417 | 1,013 | 707 | $4K | |
| 0082A | 146 | 146 | $4K | |
| J1756 | Injection, iron sucrose, 1 mg | 99 | 13 | $4K |
| 99153 | Mod sedat endo service >5yrs | 601 | 597 | $4K |
| 29125 | 500 | 351 | $4K | |
| J2401 | Injection, chloroprocaine hydrochloride, per 1 mg | 342 | 109 | $4K |
| 73620 | 608 | 596 | $4K | |
| 86735 | 456 | 450 | $4K | |
| 94729 | 843 | 843 | $4K | |
| 87177 | 1,131 | 723 | $3K | |
| 82550 | 1,378 | 1,293 | $3K | |
| 73600 | 534 | 521 | $3K | |
| J9190 | Injection, fluorouracil, 500 mg | 85 | 37 | $3K |
| 87209 | 219 | 147 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,351 | 3,097 | $3K |
| 90744 | 226 | 226 | $3K | |
| 90480 | 121 | 121 | $3K | |
| 58300 | 430 | 426 | $3K | |
| 82784 | 770 | 741 | $3K | |
| 84165 | 1,169 | 1,058 | $3K | |
| 88173 | 284 | 276 | $3K | |
| 73590 | 667 | 643 | $3K | |
| 76536 | 463 | 461 | $3K | |
| 86920 | 138 | 124 | $3K | |
| 83001 | 441 | 439 | $3K | |
| 0034A | 108 | 108 | $3K | |
| 87205 | 1,833 | 1,768 | $3K | |
| 94010 | 1,093 | 1,091 | $3K | |
| 94726 | 657 | 657 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,210 | 1,210 | $3K |
| 83883 | 766 | 581 | $3K | |
| 70491 | 71 | 70 | $3K | |
| 0154A | 99 | 99 | $3K | |
| 84999 | 710 | 650 | $3K | |
| 73090 | 499 | 470 | $2K | |
| 77065 | Tomosynthesis, mammo | 251 | 251 | $2K |
| 84146 | 721 | 716 | $2K | |
| 12011 | 248 | 246 | $2K | |
| 0074A | 90 | 90 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 963 | 931 | $2K |
| 92551 | 3,063 | 3,063 | $2K | |
| 83021 | 632 | 628 | $2K | |
| 72170 | 452 | 439 | $2K | |
| 86677 | 886 | 880 | $2K | |
| 99173 | 3,864 | 3,857 | $2K | |
| 84550 | 1,630 | 1,564 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 882 | 880 | $2K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 352 | 348 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | 877 | 764 | $2K |
| 82247 | 1,792 | 1,328 | $2K | |
| 93000 | 551 | 525 | $2K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,238 | 1,153 | $2K |
| 90381 | 86 | 86 | $2K | |
| H1003 | Prenatal care, at-risk enhanced service; education | 1,870 | 1,074 | $2K |
| 84154 | 152 | 152 | $2K | |
| 74178 | 118 | 118 | $2K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 227 | 225 | $2K |
| 87040 | 636 | 591 | $2K | |
| 72070 | 267 | 267 | $2K | |
| 0013A | 75 | 75 | $2K | |
| 85045 | 871 | 844 | $2K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 80 | 76 | $2K |
| 76870 | 285 | 281 | $2K | |
| 86225 | 447 | 441 | $2K | |
| 87902 | 207 | 204 | $2K | |
| 99205 | Prolong outpt/office vis | 712 | 689 | $2K |
| 88313 | 242 | 235 | $2K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 204 | 204 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,948 | 1,883 | $2K |
| J0461 | Injection, atropine sulfate, 0.01 mg | 1,301 | 1,241 | $2K |
| 90660 | 70 | 70 | $2K | |
| 83615 | 852 | 794 | $2K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 562 | 541 | $2K |
| 97803 | 241 | 234 | $2K | |
| 94060 | 405 | 403 | $2K | |
| 73552 | 195 | 187 | $2K | |
| 99381 | 315 | 308 | $2K | |
| 0112A | 62 | 62 | $2K | |
| 10060 | 310 | 308 | $2K | |
| 73221 | 57 | 57 | $2K | |
| 88143 | 865 | 863 | $2K | |
| H1002 | Prenatal care, at risk enhanced service; care coordination | 1,547 | 1,480 | $2K |
| 36400 | 1,338 | 1,278 | $2K | |
| 72040 | 401 | 398 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 413 | 409 | $2K |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 98 | 98 | $1K |
| 91320 | 15 | 15 | $1K | |
| 99218 | 63 | 63 | $1K | |
| 86705 | 107 | 107 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 203 | 200 | $1K |
| 12001 | 243 | 237 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | 828 | 772 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 781 | 741 | $1K |
| 93229 | 460 | 458 | $1K | |
| 0081A | 48 | 48 | $1K | |
| 72156 | 14 | 14 | $1K | |
| 93970 | 26 | 26 | $1K | |
| 82977 | 509 | 504 | $1K | |
| 29705 | 331 | 313 | $1K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 335 | 224 | $1K |
| 72146 | 14 | 13 | $1K | |
| 11056 | 130 | 116 | $1K | |
| 94664 | 89 | 88 | $1K | |
| 90734 | 1,362 | 1,355 | $1K | |
| 88307 | 84 | 79 | $1K | |
| 87252 | 289 | 281 | $1K | |
| 73700 | 26 | 25 | $1K | |
| 73522 | 214 | 214 | $1K | |
| 85651 | 705 | 701 | $1K | |
| 85379 | 482 | 476 | $1K | |
| 83718 | 666 | 666 | $1K | |
| 93975 | 13 | 12 | $983.45 | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 211 | 191 | $969.16 |
| 87045 | 525 | 520 | $965.69 | |
| 97166 | 12 | 12 | $906.56 | |
| 0250 | 488 | 355 | $905.13 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 788 | 763 | $887.57 |
| 74018 | 205 | 188 | $875.49 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 446 | 393 | $874.78 |
| J3489 | Injection, zoledronic acid, 1 mg | 103 | 98 | $856.41 |
| Z7512 | 69 | 69 | $848.65 | |
| 93246 | 25 | 24 | $827.69 | |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | 47 | 45 | $792.93 |
| 85008 | 3,261 | 3,130 | $775.91 | |
| 82330 | 268 | 251 | $773.58 | |
| 73140 | 267 | 260 | $752.20 | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 112 | 112 | $747.28 |
| 96368 | 22 | 14 | $721.90 | |
| 91318 | 27 | 27 | $702.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 131 | 123 | $691.52 |
| 74175 | 95 | 95 | $681.87 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 553 | 540 | $681.18 |
| J1815 | Injection, insulin, per 5 units | 371 | 309 | $642.58 |
| 73060 | 148 | 138 | $641.93 | |
| 87147 | 1,113 | 1,084 | $638.53 | |
| 29126 | 207 | 183 | $599.34 | |
| 99417 | Prolong home eval add 15m | 150 | 109 | $596.28 |
| 86769 | 145 | 145 | $589.82 | |
| 86431 | 510 | 510 | $588.62 | |
| 87046 | 1,045 | 520 | $555.18 | |
| 17250 | 13 | 12 | $524.17 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,348 | 2,001 | $521.21 |
| 16020 | 99 | 97 | $498.31 | |
| 82670 | 175 | 173 | $496.48 | |
| 96402 | 396 | 382 | $488.22 | |
| 92553 | 13 | 13 | $481.77 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 790 | 610 | $467.61 |
| 82810 | 244 | 224 | $459.95 | |
| 93930 | 14 | 14 | $446.65 | |
| 90672 | 170 | 169 | $446.40 | |
| 87220 | 450 | 444 | $440.86 | |
| 87493 | 135 | 131 | $412.42 | |
| 86709 | 26 | 26 | $406.49 | |
| 80320 | 290 | 268 | $404.94 | |
| 87102 | 302 | 294 | $403.92 | |
| 17110 | 30 | 28 | $399.12 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 49 | 49 | $398.59 |
| 70544 | 25 | 25 | $396.80 | |
| 29515 | 59 | 51 | $395.08 | |
| 86364 | 18 | 18 | $394.59 | |
| 71020 | 16 | 16 | $394.12 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 371 | 368 | $391.08 |
| 83520 | 26 | 26 | $390.10 | |
| 82040 | 802 | 776 | $381.98 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 51 | 29 | $381.89 |
| V5010 | Assessment for hearing aid | 50 | 50 | $377.95 |
| 99403 | 21 | 12 | $373.86 | |
| 87427 | 512 | 506 | $368.69 | |
| 11055 | 110 | 102 | $362.13 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 28 | 26 | $358.16 |
| 58301 | 83 | 52 | $356.02 | |
| 84075 | 115 | 112 | $355.08 | |
| 83002 | 181 | 180 | $348.80 | |
| 82378 | 165 | 155 | $347.66 | |
| 84155 | 677 | 661 | $345.19 | |
| 0173A | 13 | 13 | $338.00 | |
| 96156 | 159 | 155 | $337.72 | |
| 96150 | 249 | 208 | $337.18 | |
| 87350 | 398 | 395 | $336.38 | |
| 86256 | 53 | 51 | $328.98 | |
| 86359 | 61 | 61 | $325.00 | |
| 96401 | 461 | 220 | $320.86 | |
| J7050 | Infusion, normal saline solution, 250 cc | 2,763 | 1,786 | $318.62 |
| 94662 | 135 | 127 | $306.74 | |
| 86039 | 193 | 188 | $300.20 | |
| 51798 | 123 | 123 | $296.00 | |
| 92557 | 79 | 79 | $293.05 | |
| 93270 | 48 | 48 | $291.03 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 267 | 251 | $284.11 |
| 87075 | 169 | 160 | $283.60 | |
| 96151 | 290 | 250 | $277.38 | |
| 82310 | 287 | 277 | $271.11 | |
| 69210 | 94 | 88 | $268.74 | |
| 90658 | 53 | 51 | $249.70 | |
| 11100 | 61 | 61 | $246.96 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 216 | 207 | $236.31 |
| 82103 | 118 | 118 | $235.06 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 80 | 39 | $233.26 |
| J2210 | Injection, methylergonovine maleate, up to 0.2 mg | 12 | 12 | $232.69 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 57 | 55 | $223.84 |
| 57452 | 34 | 18 | $223.26 | |
| 82390 | 171 | 171 | $216.15 | |
| 73000 | 32 | 27 | $199.22 | |
| 92567 | 46 | 46 | $197.46 | |
| 36416 | 516 | 444 | $193.97 | |
| 89051 | 116 | 110 | $185.31 | |
| 72131 | 12 | 12 | $181.19 | |
| 51741 | 42 | 42 | $181.05 | |
| 76857 | 47 | 45 | $180.78 | |
| 86200 | 156 | 156 | $177.50 | |
| J1644 | Injection, heparin sodium, per 1000 units | 333 | 232 | $176.55 |
| 93225 | 90 | 90 | $171.08 | |
| J1630 | Injection, haloperidol, up to 5 mg | 109 | 102 | $169.91 |
| 86707 | 191 | 191 | $168.85 | |
| 92020 | 24 | 24 | $162.66 | |
| 99242 | 12 | 12 | $162.48 | |
| 99383 | 83 | 83 | $157.08 | |
| 76604 | 13 | 13 | $156.36 | |
| 87116 | 147 | 92 | $145.92 | |
| 76000 | 88 | 69 | $129.96 | |
| S0191 | Misoprostol, oral, 200 mcg | 172 | 171 | $124.23 |
| 29075 | 14 | 14 | $118.55 | |
| 94750 | 73 | 73 | $113.75 | |
| 31575 | 16 | 16 | $110.55 | |
| 80164 | 58 | 54 | $110.23 | |
| 99243 | 14 | 14 | $108.98 | |
| 76514 | 121 | 116 | $103.18 | |
| 81381 | 13 | 12 | $102.97 | |
| 86235 | 27 | 26 | $102.90 | |
| 84270 | 87 | 87 | $101.04 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,053 | 608 | $99.35 |
| 59200 | 13 | 12 | $93.60 | |
| 90688 | 929 | 924 | $92.68 | |
| 97168 | 337 | 335 | $87.32 | |
| 99078 | 20 | 16 | $86.59 | |
| 94760 | 67 | 66 | $80.20 | |
| 97810 | 15 | 12 | $80.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 27 | 26 | $79.07 |
| 77062 | 14 | 14 | $78.07 | |
| 84202 | 39 | 39 | $76.80 | |
| 99245 | 14 | 14 | $76.27 | |
| 86003 | 15 | 14 | $75.00 | |
| 87206 | 131 | 79 | $74.69 | |
| 87329 | 83 | 81 | $74.52 | |
| 84402 | 77 | 77 | $71.00 | |
| 17000 | 13 | 13 | $69.80 | |
| 17340 | 14 | 13 | $53.40 | |
| 80185 | 34 | 30 | $53.07 | |
| J3360 | Injection, diazepam, up to 5 mg | 47 | 46 | $52.60 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 54 | 43 | $51.52 |
| 93922 | 14 | 14 | $50.82 | |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg | 19 | 14 | $50.64 |
| 82652 | 14 | 14 | $49.40 | |
| 88172 | 25 | 25 | $48.32 | |
| 96416 | 60 | 37 | $46.19 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 42 | 41 | $45.02 |
| 86304 | 24 | 24 | $37.42 | |
| 58100 | 12 | 12 | $25.00 | |
| J1071 | Injection, testosterone cypionate, 1 mg | 90 | 53 | $22.40 |
| 88311 | 17 | 17 | $22.39 | |
| J1940 | Injection, furosemide, up to 20 mg | 39 | 38 | $21.42 |
| 82435 | 30 | 29 | $20.17 | |
| 10061 | 12 | 12 | $20.00 | |
| 96411 | 105 | 73 | $17.96 | |
| 82374 | 28 | 28 | $17.86 | |
| 83986 | 14 | 13 | $12.96 | |
| 87338 | 269 | 269 | $12.92 | |
| 86800 | 24 | 24 | $11.55 | |
| 94150 | 568 | 568 | $11.02 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 199 | 93 | $8.39 |
| 82143 | 41 | 25 | $8.36 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 14 | 14 | $7.22 |
| 84520 | 30 | 30 | $4.82 | |
| 59050 | 147 | 139 | $3.00 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 38 | 38 | $2.97 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 181 | 174 | $2.56 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 100 | 100 | $2.38 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 14 | 12 | $0.16 |
| 99451 | 2,885 | 2,865 | $0.00 | |
| 0250R | 2,070 | 1,695 | $0.00 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 117 | 87 | $0.00 |
| D0120 | Periodic oral evaluation - established patient | 24 | 24 | $0.00 |
| 99402 | 34 | 34 | $0.00 | |
| 94200 | 139 | 139 | $0.00 | |
| 96376 | 94 | 89 | $0.00 | |
| 99384 | 27 | 27 | $0.00 | |
| D0230 | Intraoral - periapical each additional radiographic image | 17 | 16 | $0.00 |
| 97162 | 79 | 79 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 635 | 236 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 143 | 139 | $0.00 |
| 00000 | 75 | 66 | $0.00 | |
| 92522 | 19 | 13 | $0.00 | |
| 86702 | 16 | 13 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 34 | 34 | $0.00 |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 42 | 40 | $0.00 |
| 96409 | 56 | 37 | $0.00 | |
| 92700 | 155 | 133 | $0.00 | |
| V2632 | Posterior chamber intraocular lens | 12 | 12 | $0.00 |
| 31231 | 12 | 12 | $0.00 | |
| 86701 | 16 | 13 | $0.00 | |
| D1310 | 16 | 16 | $0.00 | |
| D0272 | Bitewings - two radiographic images | 16 | 16 | $0.00 |
| 87015 | 22 | 13 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 21 | 21 | $0.00 |
| J2505 | Injection, pegfilgrastim, 6 mg | 15 | 14 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 207 | 206 | $0.00 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 529 | 425 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 182 | 181 | $0.00 |
| 11720 | 12 | 12 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 154 | 145 | $0.00 |
| 90685 | 12 | 12 | $0.00 | |
| 0272R | 2,036 | 1,051 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 323 | 236 | $0.00 |
| 99382 | 77 | 77 | $0.00 | |
| D0220 | Intraoral - periapical first radiographic image | 17 | 16 | $0.00 |
| 90662 | 34 | 34 | $0.00 | |
| 99404 | 165 | 142 | $0.00 | |
| D1120 | Prophylaxis - child | 18 | 18 | $0.00 |
| 0296T | 42 | 42 | $0.00 | |
| 93024 | 18 | 18 | $0.00 | |
| 97116 | 30 | 26 | $0.00 | |
| 85999 | 13 | 13 | $0.00 | |
| 97161 | 26 | 26 | $0.00 |